Friedman Lance

13D and 13G Filings

13D/G filings
13G on 2 securities
CIK
0001470622
All SEC filings
View on sec.gov
Issuer % of Class Filed
Aspire Biopharma Holdings, Inc. 13G/A Amendment 9
ASBP · 738920305
7.9% 8/6/2026
Event 8/4/2026
Aspire Biopharma Holdings, Inc. 13G/A Amendment 9
ASBP · 738920107
4.5% 5/19/2025
Event 5/6/2025
Aspire Biopharma Holdings, Inc. 13G/A Amendment 8
ASBP · 738920107
7.9% 5/7/2025
Event 4/29/2025
Aspire Biopharma Holdings, Inc. 13G/A Amendment 7
ASBP · 738920107
8.3% 4/23/2025
Event 4/21/2025
Aspire Biopharma Holdings, Inc. 13G/A Amendment 6
ASBP · 738920107
8.3% 4/17/2025
Event 4/11/2025
Aspire Biopharma Holdings, Inc. 13G/A Amendment 5
ASBP · 738920107
8.6% 4/11/2025
Event 4/4/2025
Aspire Biopharma Holdings, Inc. 13G/A Amendment 4
ASBP · 738920107
9.0% 4/4/2025
Event 3/26/2025
Aspire Biopharma Holdings, Inc. 13G/A Amendment 3
ASBP · 738920107
9.1% 3/28/2025
Event 3/19/2025
Aspire Biopharma Holdings, Inc. 13G/A Amendment 2
ASBP · 738920107
9.5% 3/20/2025
Event 3/3/2025
Aspire Biopharma Holdings, Inc. 13G/A Amendment 1
ASBP · 738920107
9.8% 3/12/2025
Event 3/3/2025
Aspire Biopharma Holdings, Inc. 13G
ASBP · 738920107
10.0%
Checked 5% or less
2/26/2025
Event 2/17/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.